Stock Hero Advertisement
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator dshade, Big_Money_Upward
Search This Board:
Last Post: 4/24/2015 2:04:17 PM - Followers: 299 - Board type: Free - Posts Today: 2

     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.


ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014

IR and Media Contacts:
Investor Relations Contact:
Media Contact:

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994

For all the latest company information, details, news, please visit

Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:


Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.


World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  


NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods. (at 28 sec into the video is a full frontal view of the ONVO NovaGen MMX Bioprinter)

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ONVO News: Current Report Filing (8-k) 04/22/2015 08:06:32 AM
ONVO News: Organovo Holdings, Inc. Pre-Announces Preliminary Fiscal 2015 Fourth Quarter And Year End Financial Information 04/21/2015 05:05:00 PM
ONVO News: Can Organovo Holdings Inc. Bounce Back? 04/17/2015 08:03:02 AM
ONVO News: Bull vs. Bear: Organovo Stock 04/13/2015 07:09:02 AM
ONVO News: Organovo Holdings Inc. Shares Cratered in March -- Here's Why 04/09/2015 12:02:03 PM
#7214  Sticky Note Article today on CNN money shorty355 11/04/14 10:44:51 AM
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#8156   I wouldn't be surprised if people lined up RandolRocketman 04/24/15 02:04:17 PM
#8155   $ONVO, WAIT 5-10 years and stock price is 50$ Mr3Deeprint 04/24/15 07:25:46 AM
#8154   BY BRITTNEY SEVENSON · APRIL 23, 2015 CommonCents4Dollars 04/23/15 04:19:53 PM
#8153   New SA article - looks positive: Organovo: Large Upside BuckeyeStocks 04/23/15 12:12:49 PM
#8152   ONVO/MERCK---EXCELLENT! dadx4 04/22/15 07:31:53 PM
#8151   Organovo Holdings (ONVO) Surges On Merck Deal CommonCents4Dollars 04/22/15 07:22:07 PM
#8150   not bad, honestly though I think it gets adeezl 04/22/15 06:38:52 PM
#8149   The fellow at Cantor is probably a Short CommonCents4Dollars 04/22/15 04:25:49 PM
#8148   Not this who who bought at $3. Windbag1014 04/22/15 03:57:25 PM
#8147   It's just about time for those who bought RallyTheMarket 04/22/15 03:41:35 PM
#8146   Healthcare Sector Movers: Organovo Holdings, Inc. (ONVO) CommonCents4Dollars 04/22/15 02:36:14 PM
#8145   ONVOs Not On Any Top Gainers Lists rumper 04/22/15 02:17:54 PM
#8144   What a turd biscuit. Who's gonna step in Tbone88 04/22/15 02:12:22 PM
#8143   Wtf is this things malfunction. Spoke to 5.30 Tbone88 04/22/15 02:06:49 PM
#8142   The SQUEEZE should be pressing up much quicker, CommonCents4Dollars 04/22/15 01:26:18 PM
#8141   Remember ONVO is also adding cash (about $150mil) dshade 04/22/15 12:32:55 PM
#8140   This Week, And Next rumper 04/22/15 12:32:46 PM
#8139   Man is this being manipulated Tbone88 04/22/15 10:23:08 AM
#8138   What If There's an 8K Every Day For_a_Week? rumper 04/22/15 10:13:17 AM
#8137   Onvo! Cbdpotential 04/22/15 10:07:30 AM
#8136   Major positive turning points for ONVO. chaostrader 04/22/15 10:02:45 AM
#8135   just let ONVO build cash position and then dshade 04/22/15 09:35:24 AM
#8134   SQUEEEEZE!!!! bettyfordallstar 04/22/15 09:22:32 AM
#8133   always buy when you see adeezl show. cheers again dshade 04/22/15 09:10:41 AM
#8132   Nice MERCK news today. dshade 04/22/15 09:09:54 AM
#8131   ONVO----GLTA! • Organovo (NYSEMKT:ONVO) enters into a multi-year collaboration dadx4 04/22/15 08:56:22 AM
#8130   ONVO 5.25 +17% GAPPA on vol on MRK PAC 04/22/15 08:53:18 AM
#8129   BOOOM!!!!'n chaostrader 04/22/15 08:21:45 AM
#8128   $ONVO GO! Mr3Deeprint 04/22/15 08:18:26 AM
#8127   Organovo Holdings, Inc. Pre-Announces Preliminary Fiscal 2015 Fourth CommonCents4Dollars 04/21/15 08:38:49 PM
#8126   The Short's Decision Cycle is_about_to_be Interrupted rumper 04/21/15 07:06:45 PM
#8125   Does anyone know where they get their cells from? too simple 04/21/15 06:33:41 PM
#8124   I'd stay short over $5 as that Cantor adeezl 04/21/15 06:29:35 PM
#8123   GO ONVO!!!! chaostrader 04/21/15 06:22:22 PM
#8122   In the meantime we can ponder the following: BuckeyeStocks 04/21/15 05:56:57 PM
#8121   Looks like $2ish is great point to load risk on 04/21/15 01:46:03 PM
#8120   We Get First Quarter 10Q in 3 Weeks rumper 04/17/15 02:18:05 PM
#8119   I really don't understand the logic of responding RallyTheMarket 04/15/15 11:44:59 AM
#8118   Hey Rally, you're right. Bravo for you! rumper 04/15/15 11:29:05 AM
#8117   Just a month or two ago the board RallyTheMarket 04/15/15 11:00:53 AM
#8116   What Have the Shorts Taught Us? rumper 04/15/15 10:05:44 AM
#8115   I guess your fellow shorters are not smart,.. CommonCents4Dollars 04/14/15 06:26:42 PM
#8114   There's your answer. ONVO. Cheers to bringing adeezl dshade 04/14/15 06:15:36 PM
#8113   Smart folks covered under $4 where I called adeezl 04/14/15 05:43:51 PM
#8112   I don't believe one bit of that.. it's adeezl 04/14/15 05:43:04 PM
#8111   10 big short squeezes besides Tesla CommonCents4Dollars 04/14/15 02:48:15 PM
#8110   SHORT SQUEEZE, 19 million losers trying to close CommonCents4Dollars 04/14/15 02:44:16 PM
#8109   Wonder if another Short Will Get anotherMarginCall? rumper 04/14/15 02:43:39 PM
#8108   What the hell is driving this, yesterday's close chef911 04/14/15 02:41:36 PM
#8107   Some shorts are foolishly trying to change the CommonCents4Dollars 04/14/15 12:49:57 PM